Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2025)
Pulse Biosciences' (PLSE) quarterly Asset Utilization Ratio came in at 0.0 in Q3 2025, down 79.01% quarter-over-quarter from 0.0 in Q1 2023.
Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Pulse Biosciences' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q3 2025; TTM through Sep 2025 was 0.0, a N/A change from a year earlier, with the FY2022 full-year figure at 0.01, down 63.35% from the prior year.
- Asset Utilization Ratio declined to 0.0 in Q3 2025 per PLSE's latest filing, from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.05 in Q2 2022 and bottomed at 0.0 in Q3 2025.
- The 3-year median for Asset Utilization Ratio is 0.01 (2022), against an average of 0.02.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 0.33 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 0.54 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 0.40 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 0.64 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 0.81 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 0.34 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 0.58 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 0.65 |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.05 |